An integrated Supply Demand Planning model for Perth. Client report to W.A. Government

Autor: McFarlane, DJ, Inman, M, Loh, MT, Scott, I, Turner, AJ, Brennan, D

Section 2 of this report details the iSDP base case and compares the current demand prediction with one based on a more detailed understanding of the factors underpinning demand. Because the base case is based on year 2000 conditions, it also estimat

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=od_______363::64b7ac567efdbb6fcf73c2ad4fd1fc0f
https://hdl.handle.net/10453/16805

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Pharmacodynamics and pharmacokinetics of single doses of prasugrel 30 mg and clopidogrel 300 mg in healthy Chinese and white volunteers: an open-label trial.

Autor: Small DS (AUTHOR), Payne CD (AUTHOR), Kothare P (AUTHOR), Yuen E (AUTHOR), Natanegara F (AUTHOR), Loh MT (AUTHOR), Jakubowski JA (AUTHOR), Lachno DR (AUTHOR), Li YG (AUTHOR), Winters KJ (AUTHOR), Farid NA (AUTHOR), Ni L (AUTHOR), Salazar DE (AUTHOR), Tomlin M (AUTHOR), Kelly R (AUTHOR)

Publikováno v: Clinical Therapeutics. Feb2010, Vol. 32 Issue 2, p365-379. 15p.

LY3437943, a novel triple GIP, GLP-1, and glucagon receptor agonist in people with type 2 diabetes: a phase 1b, multicentre, double-blind, placebo-controlled, randomised, multiple-ascending dose trial.

Autor: Urva S; Eli Lilly and Company, Indianapolis, IN, USA., Coskun T; Eli Lilly and Company, Indianapolis, IN, USA., Loh MT; Eli Lilly and Company, Indianapolis, IN, USA., Du Y; Eli Lilly and Company, Indianapolis, IN, USA., Thomas MK; Eli Lilly and Company, Indianapolis, IN, USA., Gurbuz S; Eli Lilly and Company, Indianapolis, IN, USA., Haupt A; Eli Lilly and Company, Indianapolis, IN, USA., Benson CT; Eli Lilly and Company, Indianapolis, IN, USA., Hernandez-Illas M; QPS MRA, Miami, FL, USA., D'Alessio DA; Duke Division of Endocrinology, Department of Medicine, Duke University Medical Center, Durham, NC, USA., Milicevic Z; Eli Lilly and Company, Indianapolis, IN, USA. Electronic address: milicevic_zvonko@lilly.com.

Publikováno v: Lancet (London, England) [Lancet] 2022 Nov 26; Vol. 400 (10366), pp. 1869-1881. Date of Electronic Publication: 2022 Oct 27.